ASKA Pharmaceutical Holdings: Supplementary information on financial results report for the 2nd quarter of the fiscal year ending March 31, 2024

JPX · Nov 6, 2023 14:00

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.